每年研究成果
每年研究成果
研究成果
搜尋結果
-
2020
Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort (Scientific Reports, (2020), 10, 1, (7420), 10.1038/s41598-020-64421-6)
Su, Y. Y., Chiang, N. J., Tsai, H. J., Yen, C. J., Shan, Y. S. & Chen, L. T., 2020 十二月, 於: Scientific reports. 10, 1, 20199.研究成果: Comment/debate › 同行評審
開啟存取 -
2018
Corrigendum to ‘Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study’ [Eur J Canc 81 (2017) 17–25] (S0959804917309334) (10.1016/j.ejca.2017.05.001))
Chau, I., Peck-Radosavljevic, M., Borg, C., Malfertheiner, P., Seitz, J. F., Park, J. O., Ryoo, B. Y., Yen, C. J., Kudo, M., Poon, R., Pastorelli, D., Blanc, J. F., Chung, H. C., Baron, A. D., Okusaka, T., Bowman, L., Cui, Z. L., Girvan, A. C., Abada, P. B., Yang, L. 及其他1, , 2018 九月, 於: European Journal of Cancer. 100, p. 135-136 2 p.研究成果: Comment/debate › 同行評審
4 引文 斯高帕斯（Scopus） -
2012
Erratum: APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis (Journal of Clinical Investigation (2012) 122, 1 (419) DOI:10.1172/JCI61734)
Ding, Q., Chang, C. J., Xie, X., Xia, W., Yang, J. Y., Wang, S. C., Wang, Y., Xia, J., Chen, L., Cai, C., Li, H., Yen, C. J., Kuo, H. P., Lee, D. F., Lang, J., Huo, L., Cheng, X., Chen, Y. J., Li, C. W., Jeng, L. B. 及其他7, , 2012 一月 3, 於: Journal of Clinical Investigation. 122, 1, p. 419 1 p.研究成果: Comment/debate › 同行評審
開啟存取